Home
/

Total testosterone: why the number often doesn't match how you feel

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Key takeaway:

Total testosterone measures testosterone in the blood; reference ranges are roughly 300 to 1,000 ng/dL for adult men and 10 to 70 ng/dL for women. Even one week of restricted sleep lowers morning testosterone by 10 to 15 percent in healthy men. Pairing testosterone with SHBG and free testosterone is essential because SHBG shifts can make the headline number mislead.

Read more →
Table of contents
```html

Total testosterone: a plain-language working definition

Total testosterone is the sum of all testosterone circulating in your blood at the moment of the draw. That includes the small fraction that is free and biologically active, the larger portion loosely attached to albumin, and the tightly bound fraction carried by sex hormone–binding globulin (SHBG). Most of it rides along with proteins; only a small slice is ready to act in tissues like muscle, brain, and bone.

In men, most testosterone comes from the testes under the direction of the pituitary. In women, it is made in smaller amounts by the ovaries and adrenal glands and serves as a precursor to estradiol. Because binding proteins shift with age, weight, and medications, total testosterone is a useful overview but not the whole story — SHBG context is required to make the number meaningful.

What total testosterone captures across all three fractions

Think of testosterone regulation like a thermostat. The brain senses levels, sends luteinizing hormone (LH) to the testes or ovaries, and production rises or falls to keep things steady. When illness, stress, or energy deficits hit, the brain dials back the signal to conserve resources.

Total testosterone shifts with the clock. Levels typically peak in the morning and fall by evening, which is why guidelines recommend early-morning testing for men. Sleep loss blunts that peak. In one controlled study, a week of restricted sleep lowered morning testosterone by about 10–15% in healthy young men — a change that can be felt during training and recovery.

Binding proteins play traffic cop. SHBG rises with aging and with oral estrogens, and it falls with insulin resistance and higher body fat. When SHBG rises, total testosterone can look higher even if the free fraction drops. When SHBG falls, total may look lower even if free remains adequate. Total testosterone does not tell you how much hormone is actually reaching your tissues — SHBG determines what fraction is free to act.

Acute stressors nudge levels too. Heavy endurance blocks, a calorie crunch, high alcohol intake, or an infection can suppress production for days to weeks. Lower levels in men often travel with central adiposity, insulin resistance, and sleep-disordered breathing, and are linked to higher risk for insulin resistance, anemia, and bone density loss — though causality runs both ways, because improving weight and sleep can restore levels. A single reading is a snapshot; a trend line tells the story.

Reading your total testosterone number in context

Normal ranges

Lab reference intervals describe where most people in a given population fall, not a guarantee of how you will feel. They are also method-specific. A result near the low end might be normal for the lab yet out of character for you if you have historically run higher and now have fatigue, low libido, or decreased morning erections.

For adult men, many labs cite morning total testosterone ranges around 300–1,000 ng/dL, but cutoffs vary and are being standardized through programs like the CDC Hormone Standardization initiative. Adult women's values are much lower, often in the 10–70 ng/dL range depending on age and assay, with a gradual decline after menopause. For adolescents, pregnancy, and athletes at extreme training volumes, interpretation changes with physiology.

"Optimal" is context-specific. Some studies link very low levels in men to higher risks of anemia, low bone density, and metabolic issues, while very high levels in women are tied to features of polycystic ovary syndrome and cardiometabolic risk. Patterns over time and alignment with symptoms carry more weight than one value.

High total testosterone

In men, markedly high totals often reflect external androgens, rare testicular or adrenal tumors, or increased SHBG in settings like hyperthyroidism. In women, elevated totals suggest ovarian or adrenal overproduction, as seen in polycystic ovary syndrome, late-onset congenital adrenal hyperplasia, or, less commonly, hormone-secreting tumors. Sometimes the total is high because SHBG is high — which can happen with oral estrogen therapy or pregnancy — making the free fraction look very different from the headline number.

Clues live in the company testosterone keeps. Elevated hematocrit, suppressed LH and FSH, or a high estradiol in men may point to exogenous use. In women, higher DHEA-S suggests an adrenal source, while elevated 17-hydroxyprogesterone steers toward congenital enzyme issues. If SHBG is driving the total up, calculating or directly measuring free testosterone helps right-size the picture. Confirmation matters because immunoassays can overshoot at low concentrations; mass spectrometry is preferred in women and children.

Low total testosterone

In men, low totals can arise from two main routes. Primary hypogonadism means the testes are underperforming, often with higher LH and FSH as the brain tries to compensate. Secondary hypogonadism reflects reduced pituitary signaling, from causes like obesity, sleep apnea, chronic opioid use, high stress, significant weight loss, systemic illness, or pituitary disorders. SHBG can blur the picture here too; lower SHBG in insulin resistance or hypothyroidism can pull down the total even when free testosterone is serviceable.

In women, low totals are common with combined oral contraceptives, which suppress ovarian production and raise SHBG, and after menopause, when ovarian androgen output declines. Whether low levels drive symptoms like low libido in women is debated and highly individual, which is why context and careful assessment matter more than chasing a universal cut point.

Acute illness, tough endurance blocks, or aggressive caloric deficits can temporarily suppress testosterone in anyone. Retesting when well, early in the morning for men, and paired with SHBG and free testosterone tightens the interpretation.

Factors that move your total testosterone number

Several categories of factors can shift your total testosterone result, often by acting on SHBG, the pituitary-gonadal axis, or both.

  • Sleep and circadian rhythm. Testosterone rides the circadian wave. Deep, consolidated sleep feeds the morning peak; fragmented sleep flattens it. Even a week of short sleep reduces morning testosterone by roughly 10–15% in healthy men. Sleep apnea can be a major suppressor; treatment in clinical studies has improved both symptoms and testosterone trajectories.
  • Body composition and insulin resistance. Obesity and insulin resistance lower SHBG, which can pull down total testosterone even when free fractions are adequate. Meaningful fat loss in men with obesity reliably raises total and free testosterone. Conversely, SHBG rises with aging and with oral estrogens, inflating the total while the free fraction falls.
  • Energy availability. Chronic calorie deficits signal the brain to dial down reproductive hormones — a response seen in endurance athletes and crash dieters. Stabilizing energy intake relative to output often normalizes the signal.
  • Alcohol. Heavy intake impairs testicular and ovarian steroidogenesis and disrupts sleep architecture, a double hit for morning levels.
  • Medications. Opioids and glucocorticoids suppress production. Androgen-deprivation therapies suppress it directly. Oral estrogens raise SHBG, changing total and free fractions. Thyroid status and liver health also move SHBG.
  • Acute stressors. Heavy endurance training blocks, infection, or high psychological stress can suppress production for days to weeks via elevated cortisol and reduced LH pulsatility.
  • Assay interference. High-dose biotin can interfere with immunoassay-based testosterone assays. Mass spectrometry is preferred in women and adolescents where concentrations are low and immunoassays can misestimate.

Pairing total testosterone with SHBG and free T

Total testosterone rarely tells the full story on its own. The following tests resolve the most common sources of discordance:

  • Sex hormone–binding globulin (SHBG) — the key confounder. High SHBG inflates total testosterone while free fractions fall; low SHBG in insulin resistance can make total look low while bioavailable testosterone is adequate.
  • Free testosterone — the unbound, active fraction. When total is borderline, free T separates a binding-protein shift from a true production problem.
  • Bioavailable testosterone — the free plus albumin-bound fraction. Relevant when SHBG is abnormal and a free-T calculation may be imprecise.
  • Luteinizing hormone (LH) — reveals where the bottleneck sits. High LH with low total T points to primary gonadal failure; low LH with low total T points to a pituitary or hypothalamic cause.
  • Follicle-stimulating hormone (FSH) — complements LH in mapping the axis; elevated FSH alongside elevated LH reinforces primary gonadal failure.
  • Estradiol — provides aromatization context in men (excess adipose tissue drives high estradiol, which feeds back to suppress LH) and cycle context in women with androgen excess.

Why a morning fasted retest matters for testosterone

Total testosterone is one of the more variable hormones in routine panels. A single value can be depressed by a poor night of sleep, an acute illness, or simply an afternoon draw. For this reason, clinical guidelines and standard practice specify that any low value should be confirmed with a second morning fasting draw before acting on the result.

Timing of retesting depends on context:

  • Confirming a low result: repeat as soon as practical, under the same morning fasting conditions and at the same laboratory where possible.
  • After a testosterone replacement therapy (TRT) dose change: retest at 6–8 weeks, when a new steady state has been reached.
  • After meaningful lifestyle changes (sustained sleep improvement, significant weight loss, stress reduction): retest at 6–8 weeks.
  • Routine monitoring: annually as part of a baseline panel in the absence of active treatment or symptoms.

Protocol details matter. Testosterone levels are typically 15–25% lower in the afternoon than in the morning, so an afternoon draw can mimic hypogonadism. Draw fasted, in the morning, and note any high-dose biotin supplementation — biotin can interfere with immunoassay-based testosterone assays and should be disclosed to the ordering clinician. Mass spectrometry is the preferred method in women and adolescents, where concentrations are low and standard immunoassays can misestimate.

When total testosterone warrants an endocrinology conversation

Testing gives you leverage. It separates a bad week of sleep from a months-long trend, and it ties objective data to how you feel, train, and recover. Catching a downward drift early can lead to upstream fixes — better sleep, adjusted training load, weight loss in men with obesity — that improve performance and long-term health, not just a lab value.

Consider bringing your results to a clinician when:

  • A confirmed morning fasting value falls below the lab's reference range on two separate draws.
  • Total testosterone is low alongside symptoms such as persistent fatigue, low libido, loss of morning erections, or unexplained loss of muscle mass or bone density.
  • Total testosterone is elevated in a woman alongside features of androgen excess (irregular cycles, hirsutism, acne).
  • LH and FSH are discordant with total testosterone, suggesting a pituitary or hypothalamic cause that warrants further imaging or endocrine workup.
  • Hematocrit is rising in a man on testosterone therapy — a separate safety signal that requires clinical attention.

Trended data beats snapshots. Two or three morning measurements, tested by a reliable method and paired with SHBG and free testosterone, establish a meaningful baseline. From there, you can see how specific changes ripple through your hormones over time.

A comprehensive biomarker panel shows how hormones, metabolism, sleep, and recovery interact all at once. Total testosterone is one useful signal, but its real value appears when viewed alongside SHBG, free testosterone, gonadotropins, glucose control, and lipids — then aligned with your goals and how you feel. That is how you move beyond averages toward informed, personalized decisions, grounded in evidence and guided by qualified professionals. Learn more about Superpower and our approach.

```

FAQs

Total testosterone is a blood test that measures the combined concentration of all testosterone in circulation, including both the protein-bound fraction and the small free (unbound) fraction. It is the standard first-line test for assessing testosterone status in both men and women. Total testosterone is reported in nanograms per deciliter (ng/dL) and reflects overall testosterone production by the gonads and adrenal glands.
Total testosterone is measured from a blood draw, typically collected in the morning between 7 and 10 a.m., when levels peak due to the body's natural circadian rhythm. Testing in the afternoon can yield results 15 to 25% lower than morning values, so timing matters for accurate interpretation. Results are usually available within 1 to 2 business days.
The standard adult male reference range is approximately 300 to 1,000 ng/dL, though this varies somewhat by laboratory and by the assay method used. Levels decline gradually with age, typically at about 1 to 2% per year after age 30. Reference ranges vary by lab and individual, and your provider will interpret your result alongside symptoms, free testosterone, and other relevant markers.
Low testosterone in men (hypogonadism) can stem from primary causes (testicular dysfunction) or secondary causes (insufficient signaling from the pituitary or hypothalamus). Common contributors include aging, obesity, sleep apnea, chronic stress, type 2 diabetes, certain medications, and varicocele. Identifying whether the cause is primary or secondary requires additional testing including LH, FSH, and SHBG.
Symptoms associated with low testosterone include reduced libido, difficulty maintaining muscle mass, increased body fat particularly in the midsection, fatigue, low mood or depression, poor concentration, reduced bone density over time, and in some men, erectile dysfunction. Symptoms alone are not sufficient to confirm low testosterone; blood testing is essential because these symptoms overlap with many other conditions.
Yes. Several lifestyle factors are associated with maintaining testosterone in a healthier range. Resistance training, adequate sleep (7 to 9 hours per night), maintaining a healthy body weight, limiting alcohol, managing chronic stress, and ensuring sufficient dietary zinc and vitamin D are each linked to testosterone support. These are starting points for a conversation with your clinician, not standalone treatments.

References

  1. Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018). Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. The Journal of clinical endocrinology and metabolism, 103(5), 1715-1744. https://doi.org/10.1210/jc.2018-00229
  2. Leproult, R., & Van Cauter, E. (2011). Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA, 305(21), 2173-4. https://doi.org/10.1001/jama.2011.710
  3. Brambilla, D. J., Matsumoto, A. M., Araujo, A. B., & McKinlay, J. B. (2009). The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. The Journal of clinical endocrinology and metabolism, 94(3), 907-13. https://doi.org/10.1210/jc.2008-1902
  4. Smith, S. J., Teo, S. Y. M., Lopresti, A. L., Heritage, B., & Fairchild, T. J. (2022). Examining the effects of calorie restriction on testosterone concentrations in men: a systematic review and meta-analysis. Nutrition reviews, 80(5), 1222-1236. https://doi.org/10.1093/nutrit/nuab072
  5. Shlykova, N., Davidson, E., Krakowsky, Y., Bolanos, J., Traish, A., & Morgentaler, A. (2020). Absent Diurnal Variation in Serum Testosterone in Young Men with Testosterone Deficiency. The Journal of urology, 203(4), 817-823. https://doi.org/10.1097/JU.0000000000000630

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey